Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tarsus Pharmaceuticals (TARS) Change in Inventory: 2023-2024

Historic Change in Inventory for Tarsus Pharmaceuticals (TARS) over the last 2 years, with Dec 2024 value amounting to $2.0 million.

  • Tarsus Pharmaceuticals' Change in Inventory fell 105.67% to -$37,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $988,000, marking a year-over-year decrease of 81.58%. This contributed to the annual value of $2.0 million for FY2024, which is 34.15% down from last year.
  • Per Tarsus Pharmaceuticals' latest filing, its Change in Inventory stood at $2.0 million for FY2024, which was down 34.15% from $3.1 million recorded in FY2023.
  • Over the past 5 years, Tarsus Pharmaceuticals' Change in Inventory peaked at $3.1 million during FY2023, and registered a low of $2.0 million during FY2024.
  • Its 2-year average for Change in Inventory is $2.6 million, with a median of $2.6 million in 2023.
  • Data for Tarsus Pharmaceuticals' Change in Inventory shows a maximum YoY plummeted of 34.15% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Tarsus Pharmaceuticals' Change in Inventory stood at $3.1 million in 2023, then tumbled by 34.15% to $2.0 million in 2024.